Methyldopa
- Product NDC
- 64980-571
- 11-digit product format
- 649800571
- Labeler code
- 64980
- Product ID
- 64980-571_807ace4b-b2af-44b4-9371-884d73e21601
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methyldopa
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA070076
- Marketing category
- ANDA
- Marketing start
- 2025-04-04
- Substance
- METHYLDOPA
- Active strength
- 250 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methyldopa
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHYLDOPA | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 56LH93261Y |
| Rxcui | 197956, 197958 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64980-571-01 | Methyldopa | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64980-571 | METHYLDOPA TABLET [RISING PHARMA HOLDINGS, INC.] | 3 | Current NDC, 1 package rows | 20250406_9e22e1d8-04ec-4b67-92ea-b09c706f2703.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 64980-571-01 | 64980057101 | 100 TABLET in 1 BOTTLE (64980-571-01) | 100 tablet | 2025-04-04 | No | No | Current |